Polypharmacy and comorbidity in heart failure
Authors:
- Frederick A MasoudiFMFrederick A Masoudi
- Harlan M KrumholzHKHarlan M Krumholz
Abstract
Most patients have comorbidities that need to be addressed The care of patients with heart failure has become increasingly complex. For some patients treatment based on evidence and recommended by guidelines now includes agents that prolong life, alleviate symptoms, and reduce admissions to hospital.1 2 Simultaneously, the treatment of underlying causative factors, including hypertension, coronary artery disease, and dyslipidaemia has evolved rapidly, increasing the number of pharmacological agents that are considered necessary for many patients with heart failure. The characteristics of the typical patient further complicate management. The burden of heart failure falls disproportionately on elderly people, who often are simultaneously afflicted with many other conditions.3 4 In a recent study of older Americans admitted to hospital with heart failure, diabetes (38%), chronic lung disease (33%), atrial fibrillation (30%), and prior stroke (18%), were remarkably common.5 Thus practitioners typically face the challenge of managing not a single condition but multiple conditions requiring multiple medications. As the population ages this scenario will …Keywords
This publication has 11 references indexed in Scilit:
- Serum Creatinine Is an Inadequate Screening Test for Renal Failure in Elderly PatientsArchives of internal medicine (1960), 2003
- Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international surveyThe Lancet, 2002
- Representation of the Elderly, Women, and Minorities in Heart Failure Clinical TrialsArchives of internal medicine (1960), 2002
- Randomized trial of an education and support intervention to preventreadmission of patients with heart failureJACC, 2002
- ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure)Circulation, 2001
- Guidelines for the diagnosis and treatment of chronic heart failureEuropean Heart Journal, 2001
- Candesartan in heart failure—assessment of reduction in mortality and morbidity (CHARM): Rationale and designJournal of Cardiac Failure, 1999
- Perindopril for Elderly People with Chronic Heart Failure: The PEP-CHF StudyEuropean Journal of Heart Failure, 1999
- Time to focus on the more typical heart-failure patientsThe Lancet, 1998
- A Multidisciplinary Intervention to Prevent the Readmission of Elderly Patients with Congestive Heart FailureNew England Journal of Medicine, 1995